Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cilostazol for Raynaud's phenomenon in systemic sclerosis
2010-019977-14Phase 2Active
- Sponsor
- IRCCS Ospedale Policlinico San Martino
- Start
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of cilostazol in Raynaud disease, sponsored by IRCCS Ospedale Policlinico San Martino. Primary endpoint: Primary efficacy endpoint. Started Dec 2010; status: active.
02
Drugs
cilostazol
03
Conditions
Raynaud disease
Beyond the preview
Go deeper on 2010-019977-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019977-14.